The Correlation between Thyroid-Related Hormones and Preeclampsia

doi:10.12280/gjszjk.20240112

Abstract

Abstract:

Preeclampsia (PE) is a pregnancy disorder originating from placental dysfunction, with maternal endothelial dysfunction at the core of pathogenesis. The main symptoms of PE are new-onset hypertension and proteinuria. Thyroid-related hormones have an important impact on reproduction and metabolism in women, while thyroid disorders can lead to a variety of adverse pregnancy outcomes. Thyroid-related hormones have been found to be strongly associated with PE. This paper will outline the pathways of thyroid-related hormones implicated in the pathogenesis of PE and examine the relationship between thyroid dysfunction and PE during pregnancy, with the aim of elucidating the potential role of thyroid-related hormones in the development and progression of PE.

Key words: Pregnant women, Thyroxine, Thyroid diseases, Pre-eclampsia, Pregnancy complications, Placenta

LIU Fang-lei, FENG Xiao-ling. The Correlation between Thyroid-Related Hormones and Preeclampsia[J]. Journal of International Reproductive Health/Family Planning, 2024, 43(4): 348-352.

References 32

[1]	Rybak-Krzyszkowska M, Staniczek J, Kondracka A, et al. From Biomarkers to the Molecular Mechanism of Preeclampsia-A Comprehensive Literature Review[J]. Int J Mol Sci, 2023, 24(17):13252. doi: 10.3390/ijms241713252.
[2]	Dimitriadis E, Rolnik DL, Zhou W, et al. Pre-eclampsia[J]. Nat Rev Dis Primers, 2023, 9(1):8. doi: 10.1038/s41572-023-00417-6. pmid: 36797292
[3]	Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction[J]. Biol Reprod, 2018, 99(5):907-921. doi: 10.1093/biolre/ioy115. pmid: 29767691
[4]	中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期血压管理中国专家共识(2021)[J]. 中华妇产科杂志, 2021, 56(11):737-745. doi: 10.3760/cma.j.cn112141-20210506-00251.
[5]	Jahan F, Vasam G, Green AE, et al. Placental Mitochondrial Function and Dysfunction in Preeclampsia[J]. Int J Mol Sci, 2023, 24(4):4177. doi: 10.3390/ijms24044177.
[6]	Geno KA, Nerenz RD. Evaluating thyroid function in pregnant women[J]. Crit Rev Clin Lab Sci, 2022, 59(7):460-479. doi: 10.1080/10408363.2022.2050182.
[7]	Korevaar T, Medici M, Visser TJ, et al. Thyroid disease in pregnancy: new insights in diagnosis and clinical management[J]. Nat Rev Endocrinol, 2017, 13(10):610-622. doi: 10.1038/nrendo.2017.93. pmid: 28776582
[8]	Deng C, Zhang Z, Xu F, et al. Thyroid hormone enhances stem cell maintenance and promotes lineage-specific differentiation in human embryonic stem cells[J]. Stem Cell Res Ther, 2022, 13(1):120. doi: 10.1186/s13287-022-02799-y. pmid: 35313973
[9]	Su X, Liu Y, Li G, et al. Associations of Hypothyroxinemia With Risk of Preeclampsia-Eclampsia and Gestational Hypertension[J]. Front Endocrinol(Lausanne), 2021, 12:777152. doi: 10.3389/fendo.2021.777152.
[10]	Derakhshan A, Männistö T, Chen L, et al. Association of Gestational Free and Total Triiodothyronine With Gestational Hypertension, Preeclampsia, Preterm Birth, and Birth Weight: An Individual Participant Data Meta-analysis[J]. J Clin Endocrinol Metab, 2024, 109(3):e1290-e1298. doi: 10.1210/clinem/dgad631.
[11]	Adu-Gyamfi EA, Wang YX, Ding YB. The interplay between thyroid hormones and the placenta: a comprehensive review[J]. Biol Reprod, 2020, 102(1):8-17. doi: 10.1093/biolre/ioz182. pmid: 31494673
[12]	Mallawa Kankanamalage O, Zhou Q, Li X. Understanding the Pathogenesis of Gestational Hypothyroidism[J]. Front Endocrinol(Lausanne), 2021, 12:653407. doi: 10.3389/fendo.2021.653407.
[13]	Dos Anjos Cordeiro JM, Santos LC, de Oliveira LS, et al. Maternal hypothyroidism causes oxidative stress and endoplasmic reticulum stress in the maternal-fetal interface of rats[J]. Free Radic Biol Med, 2022, 191:24-39. doi: 10.1016/j.freeradbiomed.2022.08.033.
[14]	Santos LC, de Souza CA, Silva JF, et al. Maternal hyperthyroidism alters the immunological mediators profile and population of natural killers cells in decidua of rats[J]. Acta Histochem, 2023, 125(3):152026. doi: 10.1016/j.acthis.2023.152026.
[15]	Li X, Yu T, Zhai M, et al. Maternal cadmium exposure impairs placental angiogenesis in preeclampsia through disturbing thyroid hormone receptor signaling[J]. Ecotoxicol Environ Saf, 2022, 244:114055. doi: 10.1016/j.ecoenv.2022.114055.
[16]	Santos BR, Dos Anjos Cordeiro JM, Santos LC, et al. Kisspeptin treatment improves fetal-placental development and blocks placental oxidative damage caused by maternal hypothyroidism in an experimental rat model[J]. Front Endocrinol(Lausanne), 2022, 13:908240. doi: 10.3389/fendo.2022.908240.
[17]	Liu Y, Xu Z, Li Y, et al. Effect of Preeclampsia on Ultrastructure of Thyroid Gland, Hepatic Type 1 Iodothyronine Deiodinase, and Thyroid Hormone Levels in Rats[J]. Biomed Res Int, 2021, 2021:6681491. doi: 10.1155/2021/6681491.
[18]	Businge CB, Longo-Mbenza B, Kengne AP. Mildly elevated thyroid-stimulating hormone is associated with endothelial dysfunction and severe preeclampsia among pregnant women with insufficient iodine intake in Eastern Cape province, South Africa[J]. Ann Med, 2021, 53(1):1083-1089. doi: 10.1080/07853890.2021.1947520.
[19]	Socha MW, Stankiewicz M, Żołnieewicz K, et al. Decrease in Nitric Oxide Production as a Key Mediator in the Pathogenesis of Preeclampsia and a Potential Therapeutic Target: A Case-Control Study[J]. Biomedicines, 2022, 10(10):2653. doi: 10.3390/biomedicines10102653.
[20]	Toloza F, Derakhshan A, Männistö T, et al. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis[J]. Lancet Diabetes Endocrinol, 2022, 10(4):243-252. doi: 10.1016/S2213-8587(22)00007-9.
[21]	Yang Y, Guo T, Fu J, et al. Preconception Thyrotropin Levels and Risk of Adverse Pregnancy Outcomes in Chinese Women Aged 20 to 49 Years[J]. JAMA Netw Open, 2021, 4(4):e215723. doi: 10.1001/jamanetworkopen.2021.5723.
[22]	Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum[J]. Thyroid,2017, 27(3):315-389. doi: 10.1089/thy.2016.0457. pmid: 28056690
[23]	Magri F, Bellingeri C, De Maggio I, et al. A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women[J]. J Endocrinol Invest, 2023, 46(7):1407-1414. doi: 10.1007/s40618-022-01996-z.
[24]	Businge CB, Longo-Mbenza B, Kengne AP. Iodine deficiency in pregnancy along a concentration gradient is associated with increased severity of preeclampsia in rural Eastern Cape, South Africa[J]. BMC Pregnancy Childbirth, 2022, 22(1):98. doi: 10.1186/s12884-021-04356-6.
[25]	Businge CB, Usenbo A, Longo-Mbenza B, et al. Insufficient iodine nutrition status and the risk of pre-eclampsia: a systemic review and meta-analysis[J]. BMJ Open, 2021, 11(2):e043505. doi: 10.1136/bmjopen-2020-043505.
[26]	Reische EC, Männistö T, Purdue-Smithe A, et al. The Joint Role of Iodine Status and Thyroid Function on Risk for Preeclampsia in Finnish Women: a Population-Based Nested Case-Control Study[J]. Biol Trace Elem Res, 2021, 199(6):2131-2137. doi: 10.1007/s12011-020-02341-2.
[27]	Li G, Liu Y, Su X, et al. Effect of Levothyroxine on Pregnancy Outcomes in Pregnant Women With Hypothyroxinemia: An Interventional Study[J]. Front Endocrinol(Lausanne), 2022, 13:874975. doi: 10.3389/fendo.2022.874975.
[28]	Alves Junior JM, Bernardo WM, Ward LS, et al. Effect of Hyperthyroidism Control During Pregnancy on Maternal and Fetal Outcome: A Systematic Review and Meta-Analysis[J]. Front Endocrinol(Lausanne), 2022, 13:800257. doi: 10.3389/fendo.2022.800257.
[29]	Korevaar TI, Steegers EA, Chaker L, et al. The Risk of Preeclampsia According to High Thyroid Function in Pregnancy Differs by hCG Concentration[J]. J Clin Endocrinol Metab, 2016, 101(12):5037-5043. doi: 10.1210/jc.2016-2397. pmid: 27648965
[30]	Xu Y, Li C, Wang W, et al. Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China[J]. Thyroid, 2023, 33(6):762-770. doi: 10.1089/thy.2022.0460. pmid: 37051708
[31]	《孕产期甲状腺疾病防治管理指南》编撰委员会,中华医学会内分泌学分会,中华预防医学会妇女保健分会. 孕产期甲状腺疾病防治管理指南[J]. 中华内分泌代谢杂志, 2022, 38(7):13. doi: 10.3760/cma.j.cn311282-20220416-00234.
[32]	Di Girolamo R, Liberati M, Silvi C, et al. Levothyroxine Supplementation in Euthyroid Pregnant Women With Positive Autoantibodies: A Systematic Review and Meta-Analysis[J]. Front Endocrinol(Lausanne), 2022, 13:759064. doi: 10.3389/fendo.2022.759064.